Indexado en

Licencia y uso

Citaciones

Altmetrics

Análisis de autorías institucional

Sampedro-Núñez MAutor o CoautorMarazuela MAutor o CoautorArranz Martin JaAutor o Coautor

Compartir

Satisfacción del paciente en tres sistemas avanzados de asa cerrada híbrida a los 6 meses de tratamiento en adultos con diabetes mellitus tipo 1: un estudio de seguimiento

Publicado en:Endocrinologia Diabetes y Nutricion. 70 (8): 548-555 - 2023-10-01 70(8), DOI: 10.1016/j.endinu.2023.06.005

Autores: Navas Moreno, Victor; Sebastian Valles, Fernando; Sampedro Nuñez, Miguel; Lahera Vargas, Marcos; Marazuela Azpiroz, Mónica; Arranz Martín, José Alfonso

Afiliaciones

Resumen

Introduction: Advanced hybrid closed-loop (AHCL) systems have demonstrated improved glycemic control in individuals with Type 1 Diabetes Mellitus. The aim of this study is to compare patient satisfaction among three available AHCL systems (Medtronic Minimed780G [MM780G], Roche Diabeloop DBLG1, and Tandem t:slim X2 Control IQ) after six months of treatment and to determine if it is related to glycemic control. Methods: The data of 75 individuals were analyzed, including 15 using the DBLG1 system, 9 using Control IQ, and 51 using MM780G. Patient satisfaction was assessed using the Diabetes Treatment Satisfaction Questionnaire for Diabetes Mellitus (DTSQc), a validated instrument. Results: All systems demonstrated treatment satisfaction. The DBLG-1 system scored 14 (-15 – 21) points, while Control IQ scored 21 (9 – 24) and MM780G scored 19 (11 – 24) (p = 0.004). The multivariate analysis revealed that the DBLG-1 system is associated with a lower DTSQc score (OR 0.19, p = 0.019) independently of glycemic control, sex, age, duration of diabetes, duration as an insulin pump user, and daily insulin dose. Conclusion: AHCL systems are satisfactory treatments for users, with potential variations observed between each system regardless of the achieved glycemic control.

Palabras clave